Position
Advisory Services Network, LLC in Regeneron Pharmaceuticals, Inc.
Back to the book · All holders of REGN
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $3.44K$771.93 → $772.82
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 3.89K | $3M | — | — | — | 0.0% |
| Q1 2026 | 3.95K | $3.05M | $772.82 | $3.44K | $50.2K | 0.0% |